Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi

Схожие документы

• WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
  по: Maddalena Mazzucchelli, и др.
  Опубликовано: (2018-01-01)
• Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States
  по: Jorge J Castillo, и др.
  Опубликовано: (2023-02-01)
• A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia
  по: Rayan Kaedbey, и др.
  Опубликовано: (2022-09-01)
• Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with BTK inhibitors
  по: Jingjing Zhu, и др.
  Опубликовано: (2023-04-01)
• A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia
  по: Yi Xia, и др.
  Опубликовано: (2026-12-01)